SS
Shubhangi Sanjay Patange
About Shubhangi Sanjay Patange
Data last updated:
Shubhangi Sanjay Patange is a Director at Apeksha Critical Care & Multi Speciality Hospital Private Limited (since 2007). The company operates in Healthcare. Apeksha Critical Care & Multi Speciality Hospital Private Limited reported revenue of ₹8.54 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Aug 2007 | 2007 | ₹8.54 Cr (FY 2025) | Active |
Board colleagues of Shubhangi Sanjay Patange
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arjun Ramrao Shelke | 01599894 | Apeksha Critical Care & Multi Speciality Hospital Private Limited | Director |
| Arpana Fugare Dilip | 07217328 | Apeksha Critical Care & Multi Speciality Hospital Private Limited | Director |
| Renuka Ravindra Agrawal | 01637518 | Apeksha Critical Care & Multi Speciality Hospital Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shubhangi Sanjay Patange
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shubhangi Sanjay Patange
Shubhangi Sanjay Patange currently holds 1 directorship: Apeksha Critical Care & Multi Speciality Hospital Private Limited (Director, since 07 Aug 2007, revenue ₹8.54 Cr (FY 2025)).
Shubhangi Sanjay Patange was first appointed on 07 Aug 2007 as Director at Apeksha Critical Care & Multi Speciality Hospital Private Limited.
The current boards of Shubhangi Sanjay Patange's companies include Arjun Ramrao Shelke (Apeksha Critical Care & Multi Speciality Hospital Private Limited), Arpana Fugare Dilip (Apeksha Critical Care & Multi Speciality Hospital Private Limited), Renuka Ravindra Agrawal (Apeksha Critical Care & Multi Speciality Hospital Private Limited).